Connection

Gunnar Gislason to Spironolactone

Back to Details
This is a "connection" page, showing publications Gunnar Gislason has written about Spironolactone.
Gunnar Gislason
Connection Strength
0.044
Spironolactone
  1. Mortality associated with cardiovascular drugs in patients with chronic obstructive pulmonary disease and right-sided heart failure - A danish nationwide registry-based study. Eur J Intern Med. 2019 May; 63:56-61.
    View in: PubMed
    Score: 0.044
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.